Investing.com -- GoodRx Holdings (NASDAQ:GDRX) stock surged 18% Wednesday after CEO Wendy Barnes suggested the digital healthcare platform could potentially partner with the Trump administration on its new drug pricing initiative. In an interview on Fox Business, Barnes revealed that GoodRx has been having "conversations" with the Trump administration regarding efforts to deliver more affordable drug pricing. The comments from Barnes came just one day after President Donald Trump announced a comprehensive plan aimed at reducing prescription drug costs in the United States. GoodRx, which operates a platform helping consumers find discounted prices on prescription medications, appears well-positioned to potentially benefit from or collaborate with the administration’s new drug pricing efforts. Related articlesGoodRx stock soars after CEO hints at potential TrumpRx partnershipIntel spikes on reports of potential AMD manufacturing dealAutodesk ’well-placed to monetize AI’ says HSBC